zum Inhalt wechseln
Prescription drugs Titelvorschau
SchließenTitelvorschau
Prüfung…

Prescription drugs

Verfasser/in: Sylvia Engdahl
Verlag: Detroit : Greenhaven Press/Gale Cengage Learning, ©2008.
Serien: Current controversies.
Ausgabe/Format   Print book : EnglischAlle Ausgaben und Formate anzeigen
Datenbank:WorldCat
Zusammenfassung:
Authors debate issues on prescription drugs from the safety and effectiveness of prescription drugs to the promotion and marketing of new products to the cost of prescription medications.
Bewertung:

(noch nicht bewertet) 0 mit Rezensionen - Verfassen Sie als Erste eine Rezension.

Themen
Ähnliche Titel

 

Exemplar ausleihen

&AllPage.SpinnerRetrieving; Suche nach Bibliotheken, die diesen Titel besitzen ...

Details

Physisches Format Online version:
Prescription drugs.
Detroit : Greenhaven Press/Gale Cengage Learning, ©2008
(OCoLC)768252756
Medientyp: Internetquelle
Dokumenttyp: Buch, Internet-Ressource
Alle Autoren: Sylvia Engdahl
ISBN: 9780737739626 0737739622 9780737739633 0737739630
OCLC-Nummer: 192079717
Beschreibung: 246 pages ; 24 cm.
Inhalt: Is too little attention given to the safety of prescription drugs? Yes : Problems often show up after a prescription drug is on the market. Off-label prescription of drugs can lead to adverse effects / Hazel Muir --
Some prescription drugs on the market are unsafe / Consumer reports --
Prescription drugs can cause serious harm when risks are ignored / Susan Kelleher --
Post-marketing study of prescription drugs is not adequate / David J. Graham --
No : Too much caution deprives patients of prescription drugs they need. Excessive caution in drug approval causes more harm than it prevents / Scott Gottlieb --
Panic over prescription-drug risks leads people to stop taking needed medication / Irene S. Levine --
Safety concerns about prescription drugs are exaggerated and will result in higher prices / Henry I. Miller --
Lengthy approval process for prescription drugs costs lives / Gilbert L. Ross --
Terminally ill patients should be allowed to use experimental drugs / Sigrid Fry-Revere --
Do pharmaceutical companies promote unnecessary drugs? Direct-to-consumer prescription drug advertising : an overview / Carol Rados --
Yes : Many new drugs are developed merely for commercial reasons. Pharmaceutical companies define normal conditions as diseases / Ray Moynihan, Alan Cassels --
Drug promotion plays on people's fears of future illness / Barbara Mintzes --
Drug promotion has led to the overmedication of children / Anne Taylor Fleming --
No : New drugs help people who would otherwise lack effective treatment. Drugs for minor conditions are important to many people / Glenn Harlan Reynolds --
Improved prescription drugs mean better medical treatment and less illness / Alan F. Holmer --
Direct-to-consumer prescription drug advertising helps people get treatment for undiagnosed diseases / Paul Antony. Do prescription drugs in America cost too much? Rising cost of prescription drugs : an overview --
Yes : American pharmaceutical companies charge too much. Many people cannot afford the prices set by the profit-driven drug industry / Katharine Greider --
Importing less-costly prescription drugs from abroad should be allowed / Nelda Barnett --
New cancer drugs cost more than their brief extending of life may be worth / Daniel Costello --
No : pharmaceutical companies need profits to do research. High prices of drugs for minor problems pay for drugs that cure more serious ones / Peter W. Huber --
Medical innovation would stop if the government controlled drug prices / Sidney Taurel --
Controlling drug prices would reduce access to medicine / Doug Bandow --
Are dishonest or illegal prescription drug practices common? Gifts from pharmaceutical companies influence doctors / Adriane Fugh-Berman, Shahram Ahari --
Media reporting about prescription drugs is often inaccurate / Richard A. Deyo, Donald L. Patrick --
Prescription drugs are often abused / Nichole Aksamit --
Young people often trade prescription drugs with friends / Amy Harmon --
Teens use prescription drugs to get high / Donna Leinwand.
Serientitel: Current controversies.
Verfasserangabe: Sylvia Engdahl, book editor.
Weitere Informationen:

Abstract:

Authors debate issues on prescription drugs from the safety and effectiveness of prescription drugs to the promotion and marketing of new products to the cost of prescription medications.

Rezensionen

Nutzer-Rezensionen
Suche nach GoodReads-Rezensionen
Suche nach DOGObooks-Rezensionen…

Tags

Tragen Sie als Erste Tags ein.

Ähnliche Titel

Verwandte Themen:(5)

Nutzerlisten mit diesen Titeln (2)

Anfrage bestätigen

Sie haben diesen Titel bereits angefordert. Wenn Sie trotzdem fortfahren möchten, klicken Sie auf OK.

Verlinkung


Primary Entity

<http://www.worldcat.org/oclc/192079717> # Prescription drugs
    a schema:CreativeWork, schema:Book ;
   library:oclcnum "192079717" ;
   library:placeOfPublication <http://experiment.worldcat.org/entity/work/data/119960281#Place/detroit> ; # Detroit
   library:placeOfPublication <http://id.loc.gov/vocabulary/countries/miu> ;
   schema:about <http://experiment.worldcat.org/entity/work/data/119960281#Topic/drugs_public_opinion> ; # Drugs--Public opinion
   schema:about <http://id.worldcat.org/fast/1060129> ; # Pharmaceutical industry
   schema:about <http://id.worldcat.org/fast/1060194> ; # Pharmaceutical policy
   schema:about <http://dewey.info/class/615/a14/> ;
   schema:about <http://id.worldcat.org/fast/898888> ; # Drugs--Public opinion
   schema:about <http://dewey.info/class/338.476151/e22/> ;
   schema:about <http://experiment.worldcat.org/entity/work/data/119960281#Topic/drug_industry> ; # Drug Industry
   schema:about <http://experiment.worldcat.org/entity/work/data/119960281#Topic/drug_and_narcotic_control> ; # Drug and Narcotic Control
   schema:bookFormat bgn:PrintBook ;
   schema:contributor <http://viaf.org/viaf/79537348> ; # Sylvia Engdahl
   schema:copyrightYear "2008" ;
   schema:datePublished "2008" ;
   schema:description "Authors debate issues on prescription drugs from the safety and effectiveness of prescription drugs to the promotion and marketing of new products to the cost of prescription medications."@en ;
   schema:exampleOfWork <http://worldcat.org/entity/work/id/119960281> ;
   schema:inLanguage "en" ;
   schema:isPartOf <http://experiment.worldcat.org/entity/work/data/119960281#Series/current_controversies> ; # Current controversies.
   schema:isSimilarTo <http://www.worldcat.org/oclc/768252756> ;
   schema:name "Prescription drugs"@en ;
   schema:productID "192079717" ;
   schema:publication <http://www.worldcat.org/title/-/oclc/192079717#PublicationEvent/detroit_greenhaven_press_gale_cengage_learning_2008> ;
   schema:publisher <http://experiment.worldcat.org/entity/work/data/119960281#Agent/greenhaven_press_gale_cengage_learning> ; # Greenhaven Press/Gale Cengage Learning
   schema:url <http://catdir.loc.gov/catdir/toc/ecip0812/2008010058.html> ;
   schema:workExample <http://worldcat.org/isbn/9780737739626> ;
   schema:workExample <http://worldcat.org/isbn/9780737739633> ;
   wdrs:describedby <http://www.worldcat.org/title/-/oclc/192079717> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/119960281#Agent/greenhaven_press_gale_cengage_learning> # Greenhaven Press/Gale Cengage Learning
    a bgn:Agent ;
   schema:name "Greenhaven Press/Gale Cengage Learning" ;
    .

<http://experiment.worldcat.org/entity/work/data/119960281#Series/current_controversies> # Current controversies.
    a bgn:PublicationSeries ;
   schema:hasPart <http://www.worldcat.org/oclc/192079717> ; # Prescription drugs
   schema:name "Current controversies." ;
   schema:name "Current controversies" ;
    .

<http://experiment.worldcat.org/entity/work/data/119960281#Topic/drug_and_narcotic_control> # Drug and Narcotic Control
    a schema:Intangible ;
   schema:name "Drug and Narcotic Control"@en ;
    .

<http://id.worldcat.org/fast/1060129> # Pharmaceutical industry
    a schema:Intangible ;
   schema:name "Pharmaceutical industry"@en ;
    .

<http://id.worldcat.org/fast/1060194> # Pharmaceutical policy
    a schema:Intangible ;
   schema:name "Pharmaceutical policy"@en ;
    .

<http://id.worldcat.org/fast/898888> # Drugs--Public opinion
    a schema:Intangible ;
   schema:name "Drugs--Public opinion"@en ;
    .

<http://viaf.org/viaf/79537348> # Sylvia Engdahl
    a schema:Person ;
   schema:familyName "Engdahl" ;
   schema:givenName "Sylvia" ;
   schema:name "Sylvia Engdahl" ;
    .

<http://worldcat.org/isbn/9780737739626>
    a schema:ProductModel ;
   schema:isbn "0737739622" ;
   schema:isbn "9780737739626" ;
    .

<http://worldcat.org/isbn/9780737739633>
    a schema:ProductModel ;
   schema:isbn "0737739630" ;
   schema:isbn "9780737739633" ;
    .

<http://www.worldcat.org/oclc/768252756>
    a schema:CreativeWork ;
   rdfs:label "Prescription drugs." ;
   schema:description "Online version:" ;
   schema:isSimilarTo <http://www.worldcat.org/oclc/192079717> ; # Prescription drugs
    .


Content-negotiable representations

Fenster schließen

Bitte in WorldCat einloggen 

Sie haben kein Konto? Sie können sehr einfach ein kostenloses Konto anlegen,.